Necrotizing enterocolitis: A clinical review on diagnostic biomarkers and the role of the intestinal microbiota

Inflammatory Bowel Diseases

Volumn 21, Issue 2, 2015, Pages 436-444

  Niemarkt, Hendrik J ^a,b   De Meij, Tim G ^c   Van De Velde, Mirjam E ^c   Van Der Schee, Marc P ^d   Van Goudoever, Johannes B ^c,d   Kramer, Boris W ^b   Andriessen, Peter ^a,b   De Boer, Nanne K H ^c  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Biomarkers; Microbiota; Necrotizing enterocolitis; Predictive model; Review; Volatile organic compounds

Indexed keywords

AMPICILLIN; BIOLOGICAL MARKER; CLINDAMYCIN; FATTY ACID BINDING PROTEIN 2; METRONIDAZOLE;

ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; BREAST MILK; CELL DEATH; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM PERFRINGENS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL (TOPIC); DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DYSBIOSIS; EARLY DIAGNOSIS; ECHOGRAPHY; ENZYME ACTIVITY; FECES MICROFLORA; GESTATIONAL AGE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INTESTINE FLORA; LEUKOCYTE COUNT; MESENTERY BLOOD FLOW; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); NECROTIZING ENTEROCOLITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEASONAL VARIATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; ENTEROCOLITIS, NECROTIZING; HUMAN; INTESTINE; MICROBIOLOGY; MICROFLORA; NEWBORN; RISK FACTOR;

BIOLOGICAL MARKERS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INTESTINES; MICROBIOTA; RISK FACTORS;

EID: 84927770048     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000184     Document Type: Review

References (85)

1. Dominguez KM, Moss RL. Necrotizing enterocolitis. Clin Perinatol. 2012;39:387-401.
2. Yee WH, Soraisham AS, Shah VS, et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics. 2012; 129:e298-e304.
3. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364: 255-264.
4. Crissinger KD. Regulation of hemodynamics and oxygenation in developing intestine: insight into the pathogenesis of necrotizing enterocolitis. Acta Paediatr Suppl. 1994;396:8-10.
5. Been JV, Lievense S, Zimmermann LJ, et al. Chorioamnionitis as a risk factor for necrotizing enterocolitis: A systematic review and meta-analysis. J Pediatr. 2013;162:236-242.e2.
6. Schaart MW, de Bruijn AC, Bouwman DM, et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr. 2009;49:31-41.
7. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs. 2008;68:1227-1238.
8. Wu SF, Caplan M, Lin HC. Necrotizing enterocolitis: old problem with new hope. Pediatr Neonatol. 2012;53:158-163.
9. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990;336:1519-1523.
10. Torrazza RM, Neu J. The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol. 2013;40:93-108.
11. Ahle M, Drott P, Andersson RE. Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics. 2013;132:e443-e451.
12. Snyder CL, Hall M, Sharma V, et al. Seasonal variation in the incidence of necrotizing enterocolitis. Pediatr Surg Int. 2010;26:895-898.
13. Jilling T, Simon D, Lu J, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol. 2006;177:3273-3282.
14. Cilieborg MS, Thymann T, Siggers R, et al. The incidence of necrotizing enterocolitis is increased following probiotic administration to preterm pigs. J Nutr. 2011;141:223-230.
15. Santulli TV, Schullinger JN, Heird WC, et al. Acute necrotizing enterocolitis in infancy: A review of 64 cases. Pediatrics. 1975;55:376-387.
16. Alfa MJ, Robson D, Davi M, et al. An outbreak of necrotizing enterocolitis associated with a novel clostridium species in a neonatal intensive care unit. Clin Infect Dis. 2002;35:S101-S105.
17. Gothefors L, Blenkharn I. Clostridium butyricum and necrotising enterocolitis. Lancet. 1978;1:52-53.
18. Kosloske AM, Ball WS Jr, Umland E, et al. Clostridial necrotizing enterocolitis. J Pediatr Surg. 1985;20:155-159.
19. Kosloske AM, Ulrich JA, Hoffman H. Fulminant necrotising enterocolitis associated with Clostridia. Lancet. 1978;2:1014-1016.
20. de la Cochetiere MF, Piloquet H, des Robert C, et al. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: The putative role of Clostridium. Pediatr Res. 2004;56:366-370.
21. Mai V, Young CM, Ukhanova M, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One. 2011;6:e20647.
22. Morrow AL, Lagomarcino AJ, Schibler KR, et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome. 2013;1:13.
23. Stewart CJ, Marrs EC, Magorrian S, et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr. 2012;101:1121-1127.
24. Stewart CJ, Marrs EC, Nelson A, et al. Development of the preterm gut microbiome in twins at risk of necrotising enterocolitis and sepsis. PLoS One. 2013;8:e73465.
25. Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3:944-954.
26. LaTuga MS, Ellis JC, Cotton CM, et al. Beyond bacteria: A study of the enteric microbial consortium in extremely low birth weight infants. PLoS One. 2011;6:e27858.
27. Mshvildadze M, Neu J, Shuster J, et al. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr. 2010;156:20-25.
28. Normann E, Fahlen A, Engstrand L, et al. Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr. 2013;102:129-136.
29. Sharma R, Hudak ML, Tepas JJ III, et al. Impact of gestational age on the clinical presentation and surgical outcome of necrotizing enterocolitis. J Perinatol. 2006;26:342-347.
30. Kosloske AM. Indications for operation in necrotizing enterocolitis revisited. J Pediatr Surg. 1994;29:663-666.
31. Kanto WP Jr, Hunter JE, Stoll BJ. Recognition and medical management of necrotizing enterocolitis. Clin Perinatol. 1994;21:335-346.
32. Kenton AB, O'Donovan D, Cass DL, et al. Severe thrombocytopenia predicts outcome in neonates with necrotizing enterocolitis. J Perinatol. 2005;25:14-20.
33. Song R, Subbarao GC, Maheshwari A. Haematological abnormalities in neonatal necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2012;25 (suppl 4):22-25.
34. Bizzarro MJ, Ehrenkranz RA, Gallagher PG. Concurrent bloodstream infections in infants with necrotizing enterocolitis. J Pediatr. 2014;164:61-66.
35. Epelman M, Daneman A, Navarro OM, et al. Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. Radiographics. 2007;27:285-305.
36. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368:1271-1283.
37. Buonomo C. The radiology of necrotizing enterocolitis. Radiol Clin North Am. 1999;37:1187-1198, vii.
38. Muchantef K, Epelman M, Darge K, et al. Sonographic and radiographic imaging features of the neonate with necrotizing enterocolitis: correlating findings with outcomes. Pediatr Radiol. 2013;43:1444-1452.
39. Coursey CA, Hollingsworth CL, Wriston C, et al. Radiographic predictors of disease severity in neonates and infants with necrotizing enterocolitis. AJR Am J Roentgenol. 2009;193:1408-1413.
40. Sharma R, Tepas JJ III, Hudak ML, et al. Portal venous gas and surgical outcome of neonatal necrotizing enterocolitis. J Pediatr Surg. 2005;40:371-376.
41. Hall NJ, Eaton S, Pierro A. Royal Australasia of Surgeons Guest Lecture. Necrotizing enterocolitis: prevention, treatment, and outcome. J Pediatr Surg. 2013;48:2359-2367.
42. Morrison SC, Jacobson JM. The radiology of necrotizing enterocolitis. Clin Perinatol. 1994;21:347-363.
43. Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol. 2013;40:27-51.
44. Faingold R, Daneman A, Tomlinson G, et al. Necrotizing enterocolitis: Assessment of bowel viability with color doppler US. Radiology. 2005; 235:587-594.
45. Walsh MC, Kliegman RM. Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179-201.
46. Reisinger KW, Derikx JP, Thuijls G, et al. Noninvasive measurement of intestinal epithelial damage at time of refeeding can predict clinical outcome after necrotizing enterocolitis. Pediatr Res. 2013;73:209-213.
47. Pourcyrous M, Korones SB, Yang W, et al. C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics. 2005;116:1064-1069.
48. Raval MV, Moss RL. Current concepts in the surgical approach to necrotizing enterocolitis. Pathophysiology. 2014;21:105-110.
49. Moss RL, Dimmitt RA, Barnhart DC, et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med. 2006;354:2225-2234.
50. Rees CM, Eaton S, Kiely EM, et al. Peritoneal drainage or laparotomy for neonatal bowel perforation? A randomized controlled trial. Ann Surg. 2008;248:44-51.
51. Rao SC, Basani L, Simmer K, et al. Peritoneal drainage versus laparotomy as initial surgical treatment for perforated necrotizing enterocolitis or spontaneous intestinal perforation in preterm low birth weight infants. Cochrane Database Syst Rev. 2011;15:CD006182.
52. Pierro A, Eaton S, Rees CM, et al. Is there a benefit of peritoneal drainage for necrotizing enterocolitis in newborn infants? J Pediatr Surg. 2010;45: 2117-2118.
53. Hall NJ, Curry J, Drake DP, et al. Resection and primary anastomosis is a valid surgical option for infants with necrotizing enterocolitis who weigh less than 1000 g. Arch Surg. 2005;140:1149-1151.
54. Christensen RD, Wiedmeier SE, Baer VL, et al. Antecedents of Bell stage III necrotizing enterocolitis. J Perinatol. 2010;30:54-57.
55. Miner CA, Fullmer S, Eggett DL, et al. Factors affecting the severity of necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2013;26:1715-1719.
56. Tepas JJ III, Sharma R, Leaphart CL, et al. Timing of surgical intervention in necrotizing enterocolitis can be determined by trajectory of metabolic derangement. J Pediatr Surg. 2010;45:310-313; discussion 3-4.
57. Moss RL, Kalish LA, Duggan C, et al. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: A multi-institutional study. J Perinatol. 2008;28:665-674.
58. Sylvester KG, Ling XB, Liu GY, et al. A novel urine peptide biomarkerbased algorithm for the prognosis of necrotising enterocolitis in human infants. Gut. 2014;63:1284-1292.
59. Ji J, Ling XB, Zhao Y, et al. A data-driven algorithm integrating clinical and laboratory features for the diagnosis and prognosis of necrotizing enterocolitis. PLoS One. 2014;9:e89860.
60. Yakut I, Tayman C, Oztekin O, et al. Ischemia-modified Albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis. J Clin Lab Anal. 2014;28:170-177.
61. Reisinger KW, Van der Zee DC, Brouwers HA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg. 2012;47: 1640-1645.
62. Dabritz J, Jenke A, Wirth S, et al. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr. 2012;161:1059-1064.
63. Ng EW, Poon TC, Lam HS, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg. 2013;258:1111-1118.
64. Benkoe T, Reck C, Gleiss A, et al. Interleukin 8 correlates with intestinal involvement in surgically treated infants with necrotizing enterocolitis. J Pediatr Surg. 2012;47:1548-1554.
65. Ng PC. Biomarkers of necrotising enterocolitis. Semin Fetal Neonatal Med. 2014;19:33-38.
66. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis. 2008;21:223-227.
67. Cetinkaya M, Ozkan H, Koksal N, et al. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg. 2011;46:1482-1489.
68. Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120:2989-3000.
69. Reisinger KW, Kramer BW, Van der Zee DC, et al. Non-invasive serum amyloid A (SAA) measurement and plasma platelets for accurate prediction of surgical intervention in severe necrotizing enterocolitis (NEC). PLoS One. 2014;9:e90834.
70. Richir MC, Siroen MP, van Elburg RM, et al. Low plasma concentrations of arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis. Br J Nutr. 2007;97:906-911.
71. Rabinowitz SS, Dzakpasu P, Piecuch S, et al. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr. 2001;138:81-86.
72. Terrin G, Passariello A, De Curtis M, et al. S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child. 2012;97:1102.
73. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed. 2003;88:F209-F213.
74. Thuijls G, Derikx JP, van Wijck K, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg. 2010;251:1174-1180.
75. Ng PC, Li K, Leung TF, et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem. 2006;52:1181-1189.
76. Fagerhol MK. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet. 2000;356:1783-1784.
77. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000;47:506-513.
78. Carroll D, Corfield A, Spicer R, et al. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet. 2003;361:310-311.
79. Selimoglu MA, Temel I, Yildirim C, et al. The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis. Pediatr Crit Care Med. 2012;13:452-454.
80. Hoffmann W, Jagla W, Wiede A. Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol. 2001;16:319-334.
81. Evennett NJ, Hall NJ, Pierro A, et al. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg. 2010;45:735-740.
82. Sylvester KG, Ling XB, Liu GY, et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr. 2014;164:607-612.e7.
83. Garner CE, Ewer AK, Elasouad K, et al. Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: A pilot study. J Pediatr Gastroenterol Nutr. 2009;49:559-565.
84. Perrone S, Tataranno ML, Negro S, et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants? J Matern Fetal Neonatal Med. 2012;25(suppl 1): 128-131.
85. Sampath V, Le M, Lane L, et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res. 2011;169:e51-e57.